The importing of vitamin B6 by renal proximal tubular cells from the rat is facilitated and Na'-dependent and reflects specificity for the meta-phenolate pyridinium structure with a 5-hydroxymethyl function. This transporter can, however, accept competitively each of the natural nonphosphorylated vitamers (pyridoxine, pyridoxamine, and pyridoxal) and other B6 analogues differing only in the groups at position 4. A series of N-(4'-pyridoxyl)amines was synthesized by sodium borohydride or boro[3H]hydride reduction of aldimines formed by condensing the amines with pyridoxal. The unlabeled B6-secondary amine compounds were found to competitively inhibit the uptake of [4'-3H]pyridoxine by the renal cells. Moreover, the 3H-labeled N-(4'-pyridoxyl)amines were shown to enter the cells by the process facilitated by the B6 transporter. Upon entry the labeled compounds were converted to N-(5'-phospho-4'-pyridoxyl)amines in a reaction catalyzed by pyridoxal kinase, an enzyme that tolerates considerable functional variation in position 4 of the B6 structure. The 5'-phosphates were subsequently converted within the cell to pyridoxal 5'-phosphate with liberation of the original amine in a reaction catalyzed by pyridoxamine (pyridoxine) 5'-phosphate oxidase, an enzyme with broad specificity for 4'-substituted amines on the 5'-phospho-B6 structure. This system illustrates how knowledge of transporter specificity can permit design of a compound with potential biologic activity. A drug or other intracellular effector may be piggybacked onto -a transported solute (e.g., vitamin or other nutrient) that galns facilitated entry to a cell and is, thereafter, metabolized to release tbe active compound.
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Though delivery of drugs and modulators to targets within cells has often relied on passive diffusion of a fraction of the pharmacologic levels of the compounds administered, increasing attention has been, given to more effective means that utilize biologic mechanisms for enhancing entry of compounds into cells. One such theme has been the design of liposomes with encapsulated agents that may be endocytosed (1) . Another means could conceivably utilize the ability of plasma membrane transporters to take in suitably modified solutes in carrier-mediated processes.
The transport of water-soluble vitamins by epithelial cells, such as intestinal enterocytes or renal proximal tubular cells, typically is by entry through the brush border (luminal) plasma membrane in a process that is facilitated at physiological concentration, reflects at least relative specificity for vitaminic structure, and is dependent upon Na+ cotransport (2) . Within the cell, metabolic alterations and associations with specific proteins often lead to metabolic trapping such that operational forms (e.g., coenzymes) are retained and only released through the basolateral (contraluminal) plasma membrane by reversion to the vitaminic form. The fate of vitamins with a nonepithelial cell such as the hepatocyte is somewhat similar in that transporters that contain binding proteins with relative specificity to facilitate entry are involved but Na+ pumping may not be involved (3) .
Our studies on uptake of vitamin B6 by proximal tubular cells from rat kidneys revealed a facilitated process that has substrate specificity and may be modulated by sodiumhydrogen exchange and/or pH gradient effects (4) . With the use of vesicles made from the brush-border membrane of these cells, the sodium ion dependence of the process was confirmed and the likelihood of mediation by sodiumhydrogen exchange was clarified (5) . Characteristics ofthe B6 transporter and the role of receptor/carrier proteins were clarified by the affinity isolation of specific B6-binding proteins from the brush-border membrane.* From knowledge of the specificity of the transporter (4, *), which recognizes a 2-methyl-3-hydroxy-5-hydroxymethylpyridine but can accept analogues differing at position 4, it became clear one might compete with B6 entry or even gain similar facilitated entry of N-(4'-pyridoxyl)amines, which are 4' derivatives of pyridoxamine. Moreover, because of the specificity of pyridoxal kinase (7) (8) (9) , the substituted pyridoxamines would likely be phosphorylated if they gained entry to the cytosol. Further, the resulting N-(5'-phospho-4'-pyridoxyl)amines would undoubtedly be good substrates for the pyridoxamine (pyridoxine) 5'-phosphate oxidase, which can act upon diverse 4' secondary amine derivatives of B6 phosphate (10-13). Hence, it seemed possible that compounds with amine functions could be covalently attached to vitamin B6 at position 4 to make derivatives that would gain facilitated entry into cells by using the transporter for the vitamin and then be metabolically altered to release the original amine and pyridoxal phosphate. That this is indeed the case will be demonstrated in this report. Also the broader significance for the transporter-enhanced delivery and enzyme-catalyzed release of compounds into cells will be discussed. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
MATERIALS AND METHODS

Synthesis of [4'-3H]Pyridoxine and Analogues. [4'-3H]-
Pyridoxine was synthesized by sodium boro[3H]hydride reduction of pyridoxal, and the purity was checked by TLC and a radioautogram. The final specific radioactivity was 1.17 Ci/mmol.
Unlabeled and 3H-labeled N-(4'-pyridoxyl)amines were synthesized by sodium borohydride or boro[3H]hydride reduction of aldimines formed by condensing the amines (methylamine, benzylamine, tryptamine, ethylenediamine, and 13-alanine) with pyridoxal according to the procedure described earlier (13) . The crude N-(4'-pyridoxyl)-,3-alanine was applied to a Dowex 50W (He) column, washed with water, and eluted with 1% ammonium hydroxide. The other crude N-pyridoxylamines were separately applied to Amberite CG-50 (He) and eluted with 2% (vol/vol) ammonium hydroxide. Ultraviolet spectra of the compounds were checked in acidic, basic, and neutral buffer systems, and all were comparable to a pyridoxamine standard (14) . The purity of the compounds was additionally monitored by TLC using Kodak cellulose chromagram sheets in two solvent systems: (i) methylethyl ketone/ammonia/ethanol/water, 3:1:1:1 (vol/vol), and (ii) tert-amyl alcohol/acetone/water/ diethylamine, 8:7:4:1 (vol/vol), with visualization by Gibb's reagent (2,6-dichloroquinone-4-chlorimide) or ninhydrin spray.
Specific radioactivities of the 3H-labeled N-(4'-pyridoxyl)amines were 4.10, 1.01, 0.51, 0.81, and 0.67 Ci/mmol for analogues from methylamine, benzylamine, tryptamine, ethylenediamine, and 8-alanine, respectively.
Renal Cell Isolation. Renal proximal tubular epithelial cells were isolated as described (4) from male Sprague-Dawley rats (Sasco, Omaha, NB) weighing between 220 and 320 g. For this the kidneys were perfused in situ using the recirculating collagenase method described by Jones and coworkers (15, 16) . The concentration and viability of the isolated cells were determined using a hemocytometer and noting the ability of the cells to exclude 0.2% trypan blue. Uptake was initiated by addition of [3H]pyridoxine, a mixture of [3H]pyridoxine and N-(4'-pyridoxyl)amine, or 3H-labeled N-(4'-pyridoxyl)amine. Radioactivity was assayed at various time points by applying 0.8 ml of the cell suspension to 8-,um (pore size) membrane filters (Millipore) under suction and immediately washing the cells twice with 4 ml of ice-cold Krebs-Henseleit buffer containing 12.5 mM Hepes (pH 7.4). Filtration and washing were usually completed within 12 sec. The cell blank was an identical sample kept on ice that was similarly filtered and washed immediately after adding the 3H-labeled compound. In most experiments, 0.5-min or 1-min uptake values that reflect apparent initial rates were used.
Filters with retained cells were transferred to scintillation vials, 0.5 ml of 0.5% Triton X-100 was added to lyse the cells for 10 min, and then 10 ml of Ultima-Gold scintillation fluid Samples of the aqueous cell extract were chromatographed using a 0.5 x 4 cm Dowex 1-acetate column as described by Voet et al. (18) . The cell extract and 10 Mg of pyridoxal 5'-phosphate were loaded on the column in 0.1 M ammonium acetate (pH 4.5). Pyridoxine and N-(4'-pyridoxyl)amines are not retained by the column under these conditions. The column was then washed with 0.1 M acetic acid to remove any other trace impurities and the [3H]pyridoxal 5'-phosphate was eluted with 0.1 M chloroacetic acid. Elution of pyridoxal 5'-phosphate was monitored by UV absorption (2% nm). Fractions (2.5-4 ml) were collected and radioactivity was measured in 10 ml of Ultima-Gold scintillation fluid. The specific activity of pyridoxal 5'-phosphate was assumed to be half the [3H]pyridoxine or 3H-labeled N-(4'-pyridoxyl)amine since half of the tritium is lost upon oxidation at the 4'-methylene (19) . Renal proximal tubular cells that were treated immediately after mixing with 0.5 ,uM [3H]pyridoxine or 3H-labeled N-(4'-pyridoxyl)amine after the above procedure formed only trace amounts of pyridoxal 5'-phosphate.
The overall fate of the compounds from synthesis through uptake and metabolism is shown in Fig. 1 .
RESULTS
The uptake of [3H]pyridoxine alone compared to uptake of the same amount in an equimolar mixture of each N-(4'-pyridoxyl)amine is shown in Fig. 2 generated lines with a common intercept on the 1/uptake (ordinate) axis. Since vitamin B6 is carried into cell by a transport system with relative specificity that tolerates variations at position 4' of the B6 structure, the possibility of direct uptake of N-(4'-pyridoxyl)amines was examined using the radioactive derivatives. The time courses for uptake of 3H-labeled N-(4'-pyridoxyl)amines compared to [3H]pyridoxine are shown in 
DISCUSSION
The competitive inhibition of [3H]pyridoxine uptake by N-(4'-pyridoxyl)amines and the direct uptake of the 3H-labeled analogues suggest that they utilize the same vitamin B6 transport system in rat renal proximal tubular cells. The study on their subsequent metabolism within the cells demonstrated that pyridox-:l kinase and pyridoxamine (pyridoxine) 5'-phosphate oxidase can catalyze the conversion of N-(4'-pyridoxyl)amines to pyridoxal 5'-phosphate and release the corresponding free amines (see Fig. 1 the facilitated transport of B6 (20) . Prokaryotic and eukaryotic cells have kinases (8) and oxidases (21) competent to release the amine. Hence, the present example with N-(4'-pyridoxyl)amines could be used where delivery to several tissues (e.g., liver, kidney, and brain) will result in significant release of the amine. Generally, there is facilitated entry with relative specificity for other vitamins with most cells. Studies with renal cells and riboflavin (22) or L-ascorbic acid (23) and studies with liver cells and riboflavin (24) or biotin (6) suggest transporter systems that may be utilized. In many cases, it can be anticipated that functional groups other than amines could link a vitamin or other cellular nutrient to a considerable range of drugs or intracellular effectors. This generalization is illustrated in Fig. 5 . The enhancement of effector transport by chemical linkage to solutes that gain facilitated entry followed by cleavage to release the effector may be widely applicable and is worthy offurther investigation. By selection ofthe types of transporters and levels of activities of cleavage enzymes within various cells, it should be possible to design compounds that are somewhat selective in their ultimate targets.
